As of June 2026, 2 paid clinical trials are recruiting for Breast oncology in Olympia, Washington. Breast oncology research tests new hormone therapies, HER2-targeted agents, PARP inhibitors, antibody-drug conjugates, and immunotherapy combinations across early-stage and metastatic disease. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Olympia has approximately 28 recruiting research studies across a wide range of therapeutic areas. Washington hosts Fred Hutchinson Cancer Center, UW Medicine, and Seattle Children's — widely recognized for leadership in bone marrow transplantation, immunotherapy, and infectious disease research.
Researchers run research studies in Olympia, WA at 20 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| American Oncology Network Vista Oncology Division | Gastric Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer | 3 |
| American Oncology Network Vista Oncology Division-East office | Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 3 |
| American Oncology Network Vista Oncology Division-West office | Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 3 |
| Vista Oncology | Breast Cancer, Carcinoma, Non-Small-Cell Lung | 2 |
| American Oncology Network Vista Oncology Division / Physician partner associate | Multiple Myeloma (MM) | 1 |
| American Oncology Network Vista Oncology Division/Physician Partner Associate | Hepatocellular Carcinoma (HCC) | 1 |
| Capital Clin Res Ctr,LLC | Obesity, Overweight | 1 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 1 |
| Home-based telemedicine | Chronic Granulomatous Disease (CGD) | 1 |
| Investigative Site US081 | Solid Tumors | 1 |
| Northwest Medical Specialties | Advanced Solid Tumors, Lymphoma, Non-Hodgkin, Multiple Myeloma | 1 |
| Olympia Pediatrics | Suicide Prevention | 1 |
| Olympia Surg Ctr | Lumbar Spinal Stenosis | 1 |
| Providence St. Peter Hospital | Central Line Associated Blood Stream Infections (CLABSI) | 1 |
| Vista Oncology ( Site 4201) | Diffuse Large B-Cell Lymphoma | 1 |
| Vista Oncology - East Olympia /ID# 261360 | Follicular Lymphoma (FL) | 1 |
| Vista Oncology - East Olympia /ID# 262303 | Non-Small Cell Lung Cancer | 1 |
| Vista Oncology - East Olympia /ID# 267337 | Chronic Lymphocytic Leukemia | 1 |
| Vista Oncology - East Olympia /ID# 275438 | Non Small Cell Lung Carcinoma | 1 |
| Vista Oncology Inc PS | Non-Small Cell Lung Cancer (NSCLC) | 1 |
Recruiting trials in Olympia grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Washington are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Studies in Washington must also comply with the My Health My Data Act, which adds consumer-health-data protections on top of federal HIPAA requirements.
Hipa.ai aggregates every recruiting study in Olympia from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 28 recruiting clinical trials in Olympia, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Olympia compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Olympia include Breast Cancer (2), Carcinoma, Non-Small-Cell Lung (2), Diffuse Large B-Cell Lymphoma (2), Gastric Cancer (2), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Olympia on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Olympia include American Oncology Network Vista Oncology Division, American Oncology Network Vista Oncology Division-East office, American Oncology Network Vista Oncology Division-West office, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Olympia are Cancer & tumors (20), Diabetes & metabolic (1), Cardiovascular (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.